HAP Trading’s Zymeworks ZYME Stock Holding History

HAP Trading’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,700	Closed	-$7K	–	2819
2021 Q2	$7K	Buy	+10,700	New	+$339K	﹤0.01%	2087
2021 Q1	–	Sell	-158,300	Closed	-$235K	–	2647
2020 Q4	$235K	Buy	+158,300	New	+$7.35M	0.01%	904

Other funds holding ZYME

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HAP Trading's ZYME Position: Q1 2021 in Review

HAP Trading sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 30,090 shares — an estimated $1.42M sold.

HAP Trading first reported a position in ZYME in Q4 2020 and held it in 1 quarter. The position peaked at $1.42M in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

HAP Trading reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
HAP Trading sold 30,090 Zymeworks shares in Q1 2021, an estimated $1.42M.
HAP Trading first reported a position in Zymeworks in Q4 2020 and held it in 1 quarter.
HAP Trading's Zymeworks position peaked at $1.42M in Q4 2020.
125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.